Causes of Ventricular Fibrillation
Ventricular fibrillation results from structural heart disease (primarily coronary artery disease), inherited cardiac channelopathies, drug-induced proarrhythmia, and acute metabolic/electrolyte disturbances, with ischemic heart disease being the most common underlying cause. 1
Structural Heart Disease
The dominant cause of VF is coronary artery disease and myocardial ischemia 2. Patients with three-vessel disease and prior coronary artery bypass grafting have significantly elevated risk (2.6-fold and 4-fold increased odds, respectively) 3. The mechanism involves reentrant arrhythmias arising from nonhomogeneous distribution of local hyperkalemia and acidosis in ischemic myocardium, with earliest activity originating at surviving Purkinje fibers or the epicardial rim 2.
Additional structural causes include:
- Nonischemic cardiomyopathy (dilated, hypertrophic, arrhythmogenic right ventricular cardiomyopathy) 1
- Valvular heart disease (including mitral valve prolapse) 1
- Heart failure with poor left ventricular function 1
Inherited Cardiac Channelopathies
Primary electrical diseases produce distinct VF patterns 4:
- Long QT syndrome: VF typically preceded by short-long-short sequences with very long coupling intervals (>450 ms) of the triggering beat 4
- Brugada syndrome: Unmasked or triggered by fever; sodium channel dysfunction creates substrate for VF 5, 6
- Catecholaminergic polymorphic ventricular tachycardia: VF occurs with high preceding heart rates (mean cycle length 359 ms) and short trigger coupling intervals (256 ms) 4
- Idiopathic ventricular fibrillation: Diagnosis of exclusion when structural and electrical causes ruled out 4
Drug-Induced Proarrhythmia
QT-prolonging medications are a critical reversible cause 1, 5:
- Antiarrhythmics: Class IA (quinidine), Class III (sotalol, dofetilide) cause torsades de pointes; sodium channel blockers (flecainide, propafenone) increase mortality post-MI 5
- Antibiotics: Quinolones, azithromycin, erythromycin, clarithromycin significantly increase arrhythmic death risk, especially in women 5
- Psychiatric medications: Tricyclic antidepressants produce QRS prolongation and can unmask Brugada pattern 5
- Chemotherapy: Anthracyclines cause dose-dependent cardiomyopathy; 5-fluorouracil triggers VF via coronary spasm 5
Critical pitfall: Always check www.crediblemeds.org for QT-prolonging potential and assess drug-drug interactions, particularly with CYP3A4 inhibitors 1, 5.
Metabolic and Electrolyte Disturbances
- Hypokalemia and hyperkalemia: Both extremes facilitate VF; combination of renin-angiotensin inhibitors with co-trimoxazole causing unrecognized hyperkalemia increases sudden death risk 5, 3
- Hypomagnesemia: Predisposes to torsades de pointes 5
- Acidosis: Creates substrate for reentrant arrhythmias in ischemic tissue 2
Acute Triggers and Precipitants
- Exercise and emotional stress: Particularly in channelopathies and ischemic disease 1
- Fever: Unmasks Brugada syndrome and can trigger VF even in structurally normal hearts 6
- Hypoxemia: Common precipitant in critically ill patients 6
- Bradycardia: Facilitates VF development, especially in long QT syndrome 2
- Sympathetic stimulation: Triggers VF in susceptible substrates 2
Iatrogenic Causes
During coronary angiography, VF occurs in 0.097% of procedures 3:
- Ischemia-related (48% of cases): Catheter-induced coronary occlusion
- Manipulation-related (41%): Inappropriate catheter technique
- Contrast-related (7%): Ionic contrast agents
- Electrolyte-related (4%): Acute hypokalemia
Post-Cardiac Transplant
VF occurs in >10% of transplant recipients due to 5:
- Acute rejection damaging conduction system
- Accelerated coronary vasculopathy
- Triggers during hemodialysis or plasmapheresis (hyperkalemia, hemodynamic stress)
Key Clinical Assessment Points
When evaluating VF risk, prioritize 1:
- History of prior MI, heart failure symptoms, or syncope
- Family history of sudden cardiac death, cardiomyopathy, or channelopathies
- Complete medication review including over-the-counter supplements and herbal products
- Thyroid disease, kidney disease, or chronic electrolyte abnormalities
- Substance use: Cocaine, amphetamines, anabolic steroids, alcohol
The severity of symptoms does not necessarily correlate with extent of structural disease or SCD risk 1. Patients with documented or suspected VA-related syncope require hospitalization for monitoring and evaluation 1.